 |
|
Chemotherapy-induced anemia increases risk of local breast cancer recurrence
April 01, 2008PHILADELPHIA - Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
"We speculate that there may be an interaction between chemotherapy/radiotherapy and anemia," said lead researcher Peter Dubsky, MD, a senior consultant in the department of surgery at the Medical University of Vienna, Austria. "Both treatment modalities have been shown to be less effective in anemic patients. Since we do not see the effect in terms of relapse-free survival, the interaction with local adjuvant treatment may play a more important role."
Dubsky and his colleagues from the Austrian Breast and Colorectal Cancer Study Group examined data from a randomized, clinical trial comparing adjuvant hormonal treatment and tamoxifen with the standard treatment of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). All women in the trial were premenopausal and had positive estrogen and/or progesterone receptor status. Patients who underwent breast-conserving surgery received mandatory radiation. Radiation was optional in women who underwent modified radical mastectomy.
For the current analysis, the researchers focused on anemia data from the 424 patients in the CMF arm, as the rates of anemia among those who received the hormonal treatment were low. They examined local relapse-free survival, relapse-free survival and overall survival.
Anemia occurred in 18.2 percent of patients who received CMF chemotherapy. Anemia was defined as an incidence of at least one serum hemoglobin level below 12 g/dL during chemotherapy through the first follow-up date three months after adjuvant treatment concluded.
After a median follow-up of 61 months, 39 local relapses occurred: 6.9 percent in patients without anemia and 19.5 percent in patients with anemia. The 5-year rates of relapse were 8.2 percent among nonanemic patients and 19.6 percent among anemic patients. Patients without anemia experienced a significantly longer local relapse-free survival than patients with anemia, according to the study.
Other factors that significantly increased local relapse-free survival were younger age at diagnosis and negative lymph node status. Any relationship between anemia and tumor size, postoperative radiation or type of surgery did not have an effect on local relapse-free survival, researchers say.
Relapse-free survival did not differ significantly with the presence or absence of anemia. "There seemed to be no difference when distant or contralateral events were part of the analysis," said Dubsky. "The effect was limited to local recurrences. Any explanation of the limit is pure speculation."
No difference in overall survival was evident, but Dubsky says he doubted one would be seen given the number of patients and the length of follow-up. Follow-up of 10 to 15 years would be needed to observe any significant differences, he says.
American Association for Cancer Research
For the current analysis, the researchers focused on anemia data from the 424 patients in the CMF arm, as the rates of anemia among those who received the hormonal treatment were low. They examined local relapse-free survival, relapse-free survival and overall survival.
Anemia occurred in 18.2 percent of patients who received CMF chemotherapy. Anemia was defined as an incidence of at least one serum hemoglobin level below 12 g/dL during chemotherapy through the first follow-up date three months after adjuvant treatment concluded.
After a median follow-up of 61 months, 39 local relapses occurred: 6.9 percent in patients without anemia and 19.5 percent in patients with anemia. The 5-year rates of relapse were 8.2 percent among nonanemic patients and 19.6 percent among anemic patients. Patients without anemia experienced a significantly longer local relapse-free survival than patients with anemia, according to the study.
Other factors that significantly increased local relapse-free survival were younger age at diagnosis and negative lymph node status. Any relationship between anemia and tumor size, postoperative radiation or type of surgery did not have an effect on local relapse-free survival, researchers say.
Relapse-free survival did not differ significantly with the presence or absence of anemia. "There seemed to be no difference when distant or contralateral events were part of the analysis," said Dubsky. "The effect was limited to local recurrences. Any explanation of the limit is pure speculation."
No difference in overall survival was evident, but Dubsky says he doubted one would be seen given the number of patients and the length of follow-up. Follow-up of 10 to 15 years would be needed to observe any significant differences, he says.
American Association for Cancer Research
Anemia News and Current Anemia Events RSSProtein key to control, growth of blood cells
New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and may lead to better treatments for life-threatening blood diseases.
Metabolic insight to illuminate causes of iron imbalance
New insight into key players in iron metabolism has yielded a novel tool for distinguishing among root causes of iron overload or deficiency in humans, the researchers report in the August issue of Cell Metabolism, a publication of Cell Press. While the body needs iron to produce hemoglobin, a substance in red blood cells that enables them to carry oxygen, too much iron can build up and eventually damage organs.
Key site in iron metabolism aids in diagnosing anemia of chronic disease
University of Utah School of Medicine researchers have developed a new tool that facilitates diagnosis of anemia related to chronic illness, as well as diseases of iron overload. The results of a study detailing the new tool are published in the August 2008 issue of the journal Cell Metabolism, a publication of Cell Press.
Research exposes new target for malaria drugs
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient
The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines on the role of endoscopy in the bariatric surgery patient.
Prostate cancer patients undergoing hormone therapy may experience cognitive effects
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients-- such as in the ability to recall and concentrate.
Consortium develops new method to manipulate genetic material
A multi-institutional team of researchers, including scientists at the University of Minnesota Medical School, have developed a powerful tool for genomic research and medicine.
NIST trumps the clumps: Making biologic drugs safer
Scientists at the National Institute of Standards and Technology (NIST) have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals.
Gaining ground on sickle cell disease
Although sickle cell disease is a single-gene disorder, its symptoms are highly variable. In a study published online July 14 by the Proceedings of the National Academy of Sciences, scientists at Children's Hospital Boston and the Dana Farber Cancer Institute (DFCI), in collaboration with the Broad Institute of MIT and Harvard, report five gene variants that could potentially be helpful in predicting sickle cell disease severity, perhaps even leading to better treatment approaches in the future.
New technology may prevent vitamin B12 deficient seniors and vegetarians from needing injections
For those patients who receive the nearly 40 million intramuscular injections per year to treat their B12 deficiency, a new oral option may soon exist.
More Anemia News Articles
 | Celiac Disease: A Guide to Living with Gluten Intolerance by Sylvia Llewelyn Bower Celiac disease is a digestive disorder caused by a sensitivity to the protein gluten in wheat flour, which in turn can damage the small intestine and inhibit the body’s absorption of nutrients from food. The disease is hereditary and can affect entire families. Cowritten by a registered nurse who lives with celiac disease, a dietician, and a clinical pharmacist, this indispensable guide... |
 | Understanding Anemia (Understanding Sickness & Health Series) by Ed Uthman |
 | Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease: A Biopsychosocial Approach Over recent decades, tremendous advances in the prevention, medical treatment, and quality of life issues in children and adolescents surviving cancer have spawned a host of research on pediatric psychosocial oncology. This important volume fulfills the clear need for an up-to-date, comprehensive handbook for practitioners that delineates the most recent research in the field--the first of its... |
 | Drawing Blood: Technology and Disease Identity in Twentieth-Century America (The Henry E. Sigerist Series in the History of Medicine) by Keith Wailoo "Boldly and skillfully, Wailoo analyzes not only the role of physicians but of research hospitals and pharmaceutical companies. In addition, he shows how things like race, gender, and lifestyle influenced how physicians defined and responded to the very diseases that were called into existence by the new technologies they employed." -- James H. Jones, American Historical ReviewIn Drawing Blood,... |
 | Anemia in Women: Self-Help and Treatment by Joan Gomez Many women are unaware that they have anemia. Its symptoms — fatigue, weakness, shortness of breath, headaches, and poor concentration — are often attributed to stress rather than iron deficiency. Using case studies, Joan Gomez discusses the prevention and treatment of anemia during childhood, adolescence, and... |
 | Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health by Keith Wailoo This history of the recognition, research, and treatment of sickle cell anemia provides important insight into the African American experience, race relations, and the politics of science, medicine, and... |
 | The Iron Disorders Institute Guide to Anemia More than 2 billion people worldwide have some form of anemia. Even so, the condition is greatly misunderstood and often improperly treated. In the past we were told that we should take iron supplements if we have "iron-poor blood." Now we know that there are more than a dozen types of anemia and hundreds of causes, but there is only one cause where patients might benefit from iron pills. Indeed,... |
 | Red Cell Manual by Robert S. Hillman, C. A. Finch University of Vermont, Burlington. Seventh edition of a concise guide to the diagnosis and management of red cell disorders, for students, residents, and physicians. Previous edition 1992. Halftone images and color plates. Softcover. DNLM:... |
 | Hot and Cold Health by Richard Gary Heft Health and disease are very simple. The body builds up and breaks down. Too much or too little building up or breaking down, in the extreme, tends to create symptoms, diseases that OVERBUILT (high cholesterol, arteriosclerosis, high blood pressure, cirrhosis, insomnia, gout, warts, tumors, psoriasis, fixed pain, stroke, cancer, anger, violence, etc.) OR UNDER BUILT, OVER CLEANSED (anemia, pallor,... |
 | Dr. Susan Lark's Heavy Menstrual Flow & Anemia Self Help Book: Effective Solutions for Premenopause, Bleeding Due to Fibroid Tumors, Hormonal Imbalance, ... Endometrial Cancer, and Low Blood Count by Susan M. Lark |
| © 2008 BrightSurf.com |